Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Merck Serono Supports 6th International Thyroid Awareness Week


News provided by

Merck Serono

26 May, 2014, 06:30 GMT

Share this article

Share toX

Share this article

Share toX

DARMSTADT, Germany, May 26, 2014 /PRNewswire/ --

  • For the 6th time in a row Merck Serono takes part in the International Thyroid Awareness Week with focus on HIGH FIVE  
  • Five reasons to be aware of thyroid disease: Thyroid cancer, autoimmunity, infertility, anxiety/depression, and iodine deficiency

Merck Serono, the biopharmaceutical division of Merck, together with Thyroid Federation International (TFI) today announced the International Thyroid Awareness Week, which will run from May 25 to 31, 2014. For the 6th consecutive year, Merck Serono and TFI join forces to launch the international awareness campaign this year entitled HIGH FIVE! - FIVE REASONS TO BE AWARE OF THYROID DISEASE. Five conditions associated with thyroid dysfunction will be the center of attention: thyroid cancer, autoimmunity, infertility, anxiety & depression, and iodine deficiency.

"Merck Serono is pleased to be part of the International Thyroid Awareness week. This initiative is an established and highly regarded global awareness campaign which is endorsed by the American Thyroid Association (ATA), the European Thyroid Association (ETA), the Latin American Thyroid Society (LATS) and the Chinese Society of Endocrinology (CSE)," said Meeta Gulyani, Head of Strategy and Global Franchises at Merck's biopharmaceutical division Merck Serono. Since the start of the 1st International Thyroid Awareness Week in 2009, the campaign has attracted increasing attention. Today its website (http://www.thyroidweek.com) is available in 11 languages.

Ashok Bhaseen, President of Thyroid Federation International added, "One never realizes how important the thyroid is unless it causes problems, and when it does, the impact is widespread, affecting many organs and systems. Globally, an estimated 1.6 billion people are at risk of thyroid disease and up to 60% of them could be unaware of it."

Left untreated, thyroid disorders can cause serious health problems such as cardiovascular diseases and osteoporosis[1], as well as infertility[2], mood disorders and cognitive impairment[3]. This year's campaign provides information on how to take care of the thyroid with respect to the following five conditions:

Thyroid cancer: Thyroid cancer often develops in lumps or nodules. A self-exam called "Thyroid Neck Check"[4] can help to detect nodules early. Fortunately statistics show that only one in every ten nodules harbors cancer cells. Thyroid cancer, especially if detected early, has an excellent recovery rate.[5]

Autoimmunity: The thyroid gland itself can become the target of an aberrant immune system and develop autoimmune thyroid disorders such as Hashimoto's thyroiditis or Graves' disease. Treatment of both of these disorders requires life-long medication.[6],[7]

Infertility: Thyroid dysfunction is an often over-looked cause of infertility. If women who plan to start a family don't realize the failure of their thyroid gland, they risk miscarriage, preterm delivery, and severe problems in the development of their children.[1] A normally functioning thyroid gland is essential to both men and women; thyroid hormones influence sperm production, ovulation, implantation and maintenance of a healthy pregnancy. Treatment of the thyroid disorder can restore fertility, provided thyroid failure was the only cause of infertility.[2]

Anxiety/depression: Modern imaging techniques suggest a link between hypo/hyperthyroidism and mood disorders, however relation between both is not fully understood.[3] Hypothyroid individuals have a tendency to show signs of depression and cognitive impairment, whereas hyperthyroidism is more closely linked to forms of anxiety and depression[8]. New mothers are especially vulnerable to postpartum thyroiditis (PPT) and postpartum depression.[9] Luckily, anxiety and depression that accompany thyroid dysfunction are reversible in most cases by treating the thyroid dysfunction.

Iodine deficiency: Iodine is a critical nutrient for a healthy thyroid at all stages of life. It plays an important role in festal and infant development and thyroid hormone production. An examination by a physician is the best way to find out whether the iodine supply is correct.

References:  

[1] American Thyroid Association. General Information. 2014 http://www.thyroid.org/media-main/about-hypothyroidism/ Accessed February 2014

[2] Krassas GE, Poppe K, Glinoer D (2010) Thyroid function and human reproductive health. Endocr.Rev. 2010 31:702-755

[3] Hage MP and Azar ST. The Link between Thyroid Function and Depression. J Thyroid Research 2012; 2012: 590648 doi: 10.1155/2012/590648

[4] AACE Thyroid Awareness. Neck Check. http://www.thyroidawareness.com/neck-check Accessed February 2014

[5]National Cancer Institute. SEER Stat Facts: Cancer of the Thyroid
http://seer.cancer.gov/statfacts/html/thyro.html  Accessed February 2014

[6] Chronic thyroiditis (Hashimoto's disease) http://www.nlm.nih.gov/medlineplus/ency/article/000371.htm Accessed January 2014

[7] Graves'disease. American Thyroid Association. 2012 http://www.thyroid.org/what-is-graves-disease/ Accessed January 2014

[8] Chakrabarti S. Thyroid Functions and Bipolar Affective Disorder. J Thyroid Res. 2011; 2011: 306367. Full text available: http://www.hindawi.com/journals/jtr/2011/306367/ Accessed January 2014

[9] American Thyroid Association. Postpartum thyroiditis. 2012 http://www.thyroid.org/postpartum-thyroiditis/ Accessed January 2014

About the Thyroid Federation International (TFI)  

The Thyroid Federation International first convened in Toronto at the 11th International Thyroid Congress in September 1995. Diana Meltzer Abramsky, who in 1980 founded the Thyroid Foundation of Canada in Kingston, Ontario Canada, first advocated the vision of a world thyroid patient organization to deal with the problems of thyroid disease in a global perspective. Since then the Federation has grown to include thyroid organizations in many parts of the world, including Europe, North and South America, Australia and Japan. TFI is an independent, worldwide network of patient-support organizations. The Federation works together for the benefit of those affected by thyroid disorders by providing information and raising awareness, by encouraging and assisting the formation of patient-oriented groups, and by working closely with the medical professions. TFI has a Medical Advisory Board, which consists of some of the most eminent thyroid specialists in the world.

For more information, please visit http://www.thyroid-fed.org/tfi-wp/

About Merck Serono  

Merck Serono is the biopharmaceutical division of Merck. With headquarters in Darmstadt, Germany, Merck Serono offers leading brands in 150 countries to help patients with cancer, multiple sclerosis, infertility, endocrine and metabolic disorders as well as cardiovascular diseases. In the United States and Canada, EMD Serono operates as a separately incorporated subsidiary of Merck Serono.

Merck Serono discovers, develops, manufactures and markets prescription medicines of both chemical and biological origin in specialist indications. We have an enduring commitment to deliver novel therapies in our core focus areas of neurology, oncology, immuno-oncology and immunology.

For more information, please visit http://www.merckserono.com.

All Merck Press Releases are distributed by e-mail at the same time they become available on the Merck Website. Please go to http://www.merckgroup.com/subscribe to register online, change your selection or discontinue this service.

Merck is a leading company for innovative and top-quality high-tech products in the pharmaceutical and chemical sectors. With its four divisions Merck Serono, Consumer Health, Performance Materials and Merck Millipore, Merck generated total revenues of € 11.1 billion in 2013. Around 38,000 Merck employees work in 66 countries to improve the quality of life for patients, to further the success of customers and to help meet global challenges. Merck is the world's oldest pharmaceutical and chemical company - since 1668, the company has stood for innovation, business success and responsible entrepreneurship. Holding an approximately 70 percent interest, the founding family remains the majority owner of the company to this day. Merck, Darmstadt, Germany is holding the global rights to the Merck name and brand. The only exceptions are Canada and the United States, where the company is known as EMD.

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.